127 related articles for article (PubMed ID: 6367694)
1. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
Crivii SM; Crişan M; Crişan M
Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
[TBL] [Abstract][Full Text] [Related]
2. Migration inhibition factor activity in sera of patients with chronic lymphatic leukemia.
Benjamin D; Aderka D; Livni E; Joshua H; Shaklai M; Pinkhas J
J Natl Cancer Inst; 1979 Nov; 63(5):1175-7. PubMed ID: 388014
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.
Gorski AJ; Dupont B; Hansen JA; Safai B; Pahwa S; Good RA
J Immunol; 1977 Mar; 118(3):858-62. PubMed ID: 139447
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood.
Skopińska E; Lukasik R
Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792
[TBL] [Abstract][Full Text] [Related]
5. [The functional characteristics of the interaction of lymphokine-producing lymphocytes with granulocytes of the peripheral blood and skin in dermatosis patients].
Kozin VM; Adamenko GP; Bogdanovich LI; Iakirevich EV
Vestn Dermatol Venerol; 1990; (3):29-32. PubMed ID: 2195796
[TBL] [Abstract][Full Text] [Related]
6. Impaired cellular interactions involving lymphocytes from patients with chronic lymphocytic leukemia and ataxia-telangiectasia.
Weisbart RH; Kacena A; Golde DW; Costea NV
J Lab Clin Med; 1980 Jul; 96(1):114-8. PubMed ID: 6993592
[TBL] [Abstract][Full Text] [Related]
7. Prevention of leukocyte migration inhibitory factor activity by glucagon.
Pereţianu D; Deleanu A; Lotreanu V; Mogoş A; Beşliu C; Tănase D
Med Interne; 1985; 23(1):63-6. PubMed ID: 2986274
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte migration inhibitory factor (LMIF) release by human colonic lymphocytes.
Bartnik W; ReMine SG; Shorter RG
Arch Immunol Ther Exp (Warsz); 1981; 29(3):397-405. PubMed ID: 6271090
[TBL] [Abstract][Full Text] [Related]
9. The effect of corticosteroids and other antineoplastic agents on the generation of leukocyte migration inhibition factor.
Li J; Yousefi S; Sterling M; Carandang G; Vaziri N; Pahl M; Cesario T
J Clin Lab Immunol; 1987 Jan; 22(1):13-7. PubMed ID: 3104595
[TBL] [Abstract][Full Text] [Related]
10. Leucocyte migration inhibitory factor assay in Nigerians with urinary schistosomiasis.
Arinola OG; Salimonu LS
West Afr J Med; 1999; 18(2):101-5. PubMed ID: 10504865
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the pathogenic mechanism of hypersensitivity to antibacterial agents--correlations of leucocyte migration activating factor and leucocyte migration inhibitory factor with interleukin-2 and interferon-gamma].
Uno K
Arerugi; 1993 May; 42(5):656-64. PubMed ID: 8323465
[TBL] [Abstract][Full Text] [Related]
12. [Determination of a factor inhibiting migration of leukocytes to brain antigens, its concentration in serum and spontaneous leukocyte migration in multiple sclerosis].
Loĭko TP; Ierusalimskiĭ AP; Lozovoĭ VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):187-90. PubMed ID: 3518311
[TBL] [Abstract][Full Text] [Related]
13. [The immune status of patients with foot mycosis and eczema].
Iutskovskiĭ AD
Vestn Dermatol Venerol; 1989; (1):52-7. PubMed ID: 2524143
[TBL] [Abstract][Full Text] [Related]
14. [Leukocyte migration inhibition test for functional evaluation of the T-lymphocyte population].
Bilynskaia KhZ; Loginskiĭ VE
Lab Delo; 1980; (5):316-7. PubMed ID: 6156295
[No Abstract] [Full Text] [Related]
15. Cellular collaboration in the production of human leucocyte migration inhibition factor.
Weisbart RH; Yu DT; Billing R; Fan PT; Clements PJ; Paulus HE
Immunology; 1978 May; 34(5):815-9. PubMed ID: 306961
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte migration inhibition factor (LIF) increases polymorphonuclear cell endocytosis.
Cortés-Castillo MA; Favila-Castillo L
Arch Invest Med (Mex); 1991; 22(1):35-40. PubMed ID: 1819974
[TBL] [Abstract][Full Text] [Related]
17. "In vitro" and "in vivo" leukocyte migration inhibitory factor production in acute infectious mononucleosis patients.
Bertotto A; Gentili F; Stagni G; Zucchetti Z; Vaccaro R
Boll Ist Sieroter Milan; 1983 Jul; 62(3):281-6. PubMed ID: 6357231
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte migration inhibitory factor in HSV infections.
Centifanto YM; Zam ZS; McNeill JI; Kaufman HE
Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):863-8. PubMed ID: 212384
[TBL] [Abstract][Full Text] [Related]
19. In vitro assay for responsiveness of lymphocytes to transfer factor by a new leukocyte migration inhibitory test.
Miyagawa Y; Kawasaki A; Komiyama A; Akabane T
Microbiol Immunol; 1978; 22(11):701-10. PubMed ID: 370507
[TBL] [Abstract][Full Text] [Related]
20. Regulation of lymphocyte motility by macrophages: characterization of a lymphocyte migration inhibitory factor derived from a macrophage-like cell line.
Ye S; Cheung HT
Cell Immunol; 1989 Aug; 122(1):231-43. PubMed ID: 2665945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
